Toggle
Corporates
> Rallybio
Rallybio
Despite sciences best efforts, rare diseases remain far too common. Its time to tackle the undone, the too difficult, and the inaccessible
Number of Partnerships: 10
Startup
Alpha Score
HealthTech Category
Proposition
Technology
Country
Stage
Current Funding
